Weis Markets Reports Revenue Growth Amid Pharmacy Headwinds

The Sunbury-based grocery chain saw its total revenue reach $2.53 billion for the first half of 2026, marking a 4.6% rise over the same period in 2025. Comparable store sales grew by 2.3% during the quarter, supported by a two-year stacked increase of 4.1%. However, the bottom line felt the impact of regulatory changes, specifically the Inflation Reduction Act’s Medicare maximum fair price provisions. These provisions created pricing headwinds that reduced pharmacy revenue growth by approximately $10.71 million during the second quarter alone.

Net income for the 13-week period ending June 27, 2026, fell to $22.86 million, down from $25.28 million in 2025. Earnings per share followed a similar trend, slipping to $0.92 from $0.96. Despite the quarterly dip, year-to-date performance remains resilient with net income totaling $50.71 million, a 13.1% improvement over the previous year. Chairman and CEO Jonathan H. Weis noted that the company is leaning into promotional investments and loyalty marketing to maintain customer engagement as shoppers continue to prioritize affordability.